← All trends
World Wellness Guide
National Trend
Weight loss

GLP-1 family: 26.8M searches a month

3.9M
searches/mo for the #1 result on "GLP-1 family funnel"
1Mounjaro7.8M/mo7.8M2Ozempic4.7M/mo, -7% 6mo4.7M3Glp 13.9M/mo, +10% 6mo3.9M4Tirzepatide3.2M/mo, +28% 6mo3.2M5Wegovy3M/mo, +9% 6mo3M6Semaglutide2.1M/mo2.1M7Zepbound1.1M/mo, +6% 6mo1.1M8Medical Weight Loss973K/mo, +29% 6mo973K
Confidence: StrongAs of 2026-07-10

global · market pattern

GLP-1 family: 26.8M searches a month

The GLP-1 family draws about 26.8M searches a month across 30 markets. Awareness sits in the class term GLP-1, but purchase demand concentrates in the brands, led by Mounjaro.

The GLP-1 boom, mapped as one family: how awareness in the class term turns into demand for specific brands.

What it isthe full GLP-1 weight-loss family: the drug class plus its branded members.

Working hypothesisAI-suggested

The class term GLP-1 captures awareness; the money and purchase intent live in the branded members, Mounjaro and Ozempic lead. Read the family to see the whole funnel.

The evidence

family total
about 26.8M searches a month across the family, summed over 30 markets [MEASURED, upper bound: members overlap]
awareness vs purchase
class term GLP-1 = 3.9M/mo (awareness); brand leader Mounjaro = 7.8M/mo (purchase tier) [MEASURED]
note
A class term shows awareness alone; its purchase tier lives in the sibling brands. Family totals are an upper bound because members overlap. Search demand, not sales.

The full ranking

8 tracked · GLP-1 family funnel.

  1. 1Mounjaro7.8M/mo
  2. 2Ozempic4.7M/mo, -7% 6mo
  3. 3Glp 13.9M/mo, +10% 6mo
  4. 4Tirzepatide3.2M/mo, +28% 6mo
  5. 5Wegovy3M/mo, +9% 6mo
  6. 6Semaglutide2.1M/mo
  7. 7Zepbound1.1M/mo, +6% 6mo
  8. 8Medical Weight Loss973K/mo, +29% 6mo